Mary Kelly
Internal Medicine · West Seneca, NYNPI 1053361816
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.9% of the total across 306 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 32 manufacturers, the largest accounting for just 14.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,459 and has fallen 99.0% since, to $15 in 2023.
Across 306 payments — averaging $15.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$664
- Novo Nordisk$483
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$382
- AstraZeneca$360
- Boehringer Ingelheim$329
- AbbVie$248
- plus $2K from 26 others
What the payments were for
- Food & beverage$4,63898%
- Education$1002%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 47 | $664 |
| Novo Nordisk | 44 | $483 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 27 | $382 |
| AstraZeneca | 20 | $360 |
| Boehringer Ingelheim | 19 | $329 |
| AbbVie(2 entities) | 15 | $248 |
| Johnson & Johnson | 25 | $228 |
| Lilly USA, LLC | 15 | $225 |
| Astellas Pharma US Inc | 5 | $170 |
| Sanofi-aventis U.S. LLC | 11 | $168 |
| Collegium Pharmaceutical, Inc. | 5 | $167 |
| Amgen | 11 | $153 |
| Amarin Pharma, Inc. | 8 | $140 |
| Pfizer | 9 | $131 |
| Merck | 8 | $125 |
| Ironwood Pharmaceuticals, Inc | 2 | $110 |
| Novartis | 6 | $103 |
| Bayer | 1 | $100 |
| Kowa Pharmaceuticals America, Inc. | 3 | $52 |
| Abbott | 3 | $46 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $40 |
| E.r. Squibb & Sons, L.L.C. | 3 | $40 |
| Sanofi Pasteur Inc. | 2 | $39 |
| Scilex Pharmaceuticals Inc. | 2 | $38 |
| Otsuka America Pharmaceutical, Inc. | 2 | $38 |
| Eisai Inc. | 2 | $32 |
| Dexcom, Inc. | 2 | $29 |
| Avanir Pharmaceuticals, Inc. | 1 | $24 |
| Esperion Therapeutics, Inc. | 2 | $23 |
| Grifols USA, LLC | 1 | $20 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $17 |
| Zyla Life Sciences, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XTAMPZA$125
- TRELEGY ELLIPTA$117
- Kerendia$100
How this compares
$4,738 in reported general payments places this provider in the 85th percentile of 9,771 internal medicine providers in New York.
Other internal medicine in West Seneca
- David DoveEast Hampton$12.3M
- Bruce BergerBrooklyn$3.4M
- Nicholas RobinsonBuffalo$2.9M
- Stephen SaletanNew York$2.6M
- Ziad AliNew York$2M
- Scott BeegleAlbany$1.9M
- Anthony MartinezBuffalo$1.6M
- Javier MoralesGreenvale$1.3M
- Ricky HsuNew York$1M
- James UnderbergNew York$953K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.